OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2005
INTERVENTION: Trade Name: ZYPREXA VELOTAB*28 CPR 5 MG Pharmaceutical Form: Tablet INN or Proposed INN: Olanzapine CAS Number: 132539‐06‐1 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5‐ Trade Name: LAMICTAL*25MG 28 CPR DISP. Pharmaceutical Form: Chewable tablet INN or Proposed INN: Lamotrigine CAS Number: 84057‐84‐1 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 25‐ CONDITION: EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS ; MedDRA version: 6.1 Level: PT Classification code 10057667 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 04cff77b06109445e7f74d6926830cf5c2312108
First added on: Aug 21, 2024